International Journal of Cancer Management

Published by: Kowsar

Frequency of Chemotherapy Induced Anemia in Breast Cancer Patients

Leila Pourali 1 , Ali Taghizadeh 2 , * , Mohammad Reza Akhoundi 3 , Fatemeh Varshoei 3 , Ahmadreza Zarifian 4 and Mohammad Sobhan Sheikh Andalibi 4
Authors Information
1 Department of Obstetrics and Gynecology, Women’s Health Research Center, School of Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Department of Clinical Oncology, Cancer Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Imam Reza Hospital, Mashhad, IR Iran
4 Medical student, Student Research Committee, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: January 2017, 10 (1); e4672
  • Published Online: September 27, 2016
  • Article Type: Research Article
  • Received: November 11, 2015
  • Revised: April 23, 2016
  • Accepted: September 24, 2016
  • DOI: 10.17795/ijcp-4672

To Cite: Pourali L, Taghizadeh A, Akhoundi M R, Varshoei F, Zarifian A, et al. Frequency of Chemotherapy Induced Anemia in Breast Cancer Patients, Int J Cancer Manag. 2017 ; 10(1):e4672. doi: 10.17795/ijcp-4672.

Abstract
Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Lyman GH, Berndt ER, Kallich JD, Erder MH, Crown WH, Long SR, et al. The economic burden of anemia in cancer patients receiving chemotherapy. Value Health. 2005; 8(2): 149-56[DOI][PubMed]
  • 2. Goldrick A, Olivotto IA, Alexander CS, Speers CH, Barnett J, Allan SJ, et al. Anemia is a common but neglected complication of adjuvant chemotherapy for early breast cancer. Curr Oncol. 2007; 14(6): 227-33[PubMed]
  • 3. Dicato M. Anemia in cancer: some pathophysiological aspects. Oncologist. 2003; 8 Suppl 1: 19-21[PubMed]
  • 4. Rodgers G3, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, et al. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. 2012; 10(5): 628-53[PubMed]
  • 5. Spivak JL. The anaemia of cancer: death by a thousand cuts. Nat Rev Cancer. 2005; 5(7): 543-55[DOI][PubMed]
  • 6. Barrett-Lee P, Bokemeyer C, Gascon P, Nortier JW, Schneider M, Schrijvers D, et al. Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey. Oncologist. 2005; 10(9): 743-57[DOI][PubMed]
  • 7. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst. 1999; 91(19): 1616-34[PubMed]
  • 8. Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer. 2002; 95(1): 155-63[DOI][PubMed]
  • 9. Fauci AS. Harrison's principles of internal medicine. 2008; 2
  • 10. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. Breast J. 2007; 13(4): 383-91[DOI][PubMed]
  • 11. Schwartz RN. Anemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocols. Am J Health Syst Pharm. 2007; 64(3 Suppl 2)-13[DOI][PubMed]
  • 12. Steensma DP. Is anemia of cancer different from chemotherapy-induced anemia? J Clin Oncol. 2008; 26(7): 1022-4[DOI][PubMed]
  • 13. Vadhan-Raj S, Mirtsching B, Charu V, Terry D, Rossi G, Tomita D, et al. Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks. J Support Oncol. 2003; 1(2): 131-8[PubMed]
  • 14. Harrison LB, Shasha D, White C, Ramdeen B. Radiotherapy-associated anemia: the scope of the problem. Oncologist. 2000; 5 Suppl 2: 1-7[PubMed]
  • 15. Kirshner J, Hatch M, Hennessy DD, Fridman M, Tannous RE. Anemia in stage II and III breast cancer patients treated with adjuvant doxorubicin and cyclophosphamide chemotherapy. Oncologist. 2004; 9(1): 25-32[PubMed]
  • 16. Coiffier B, Guastalla JP, Pujade-Lauraine E, Bastit P, Anemia Study G. Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey. Eur J Cancer. 2001; 37(13): 1617-23[PubMed]
  • 17. Kitano T, Tada H, Nishimura T, Teramukai S, Kanai M, Nishimura T, et al. Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy. Int J Hematol. 2007; 86(1): 37-41[DOI][PubMed]
  • 18. Hassan BA, Yusoff ZB, Hassali MA, Othman SB. Association and correlation of different chemotherapeutic regimens and doses with onset and severity of anemia among solid cancer patients. Asian Pac J Cancer Prev. 2011; 12(10): 2753-8[PubMed]
  • 19. Chaumard N, Limat S, Villanueva C, Nerich V, Fagnoni P, Bazan F, et al. Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapy. Breast. 2012; 21(4): 464-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments